Microbiological profile of isolated patogens from urethral and vaginal secretions
Article Sidebar
Article Details
Authors
Publication Information
Keywords
Drug Resistance, Microbial
Leukorrhea
Abstract
Received: Nov 6, 2018 Accepted: Apr 10, 2019
Purpose: To determine the microbiological profile of isolated pathogens in the vaginal and urethral secretion of the adult population between ages 18 to 60 years in outpatient clinic of the Sexually Transmitted Infections (STI) of zone 3 Health Center, Municipality of Guatemala, Department of Guatemala, during June–July 2018.
Population and methods: Descriptive, cross sectional study developed in a convenience sample of 120 outpatients of both sexes who consulted the STI clinic.
Results: The predominant age group was from 18 to 22 years, only 2 patients were male. Microbial growth was evidenced in 59 samples, 66 pathogens were isolated: Candida albicans 36.3% (24)9, Gardnerella vaginalis 25.7% (17), Candida glabrata 16.65% (11), Trichomona vaginalis 15.1% (10), Candida parapsilosis 3% (2) and Neisseria gonorrhoeae 3% (2). We having found 7 case of mixed infection. The predominant clinical simptomatology was thitish, semelly discharge, > 2 weeks of evolution with itching and pain. Antimicrobial resistance: Candida glabrata presented 63.64% (7) and Candida albicans 41.7% (10) to fluconazole, Gardnerella vaginalis 53% (9) to metronidazole and clindamycin and Neisseria gonorrhoeae 50% (1) to ciprofloxacin, cefexime and ceftriaxone.
Conclusions: The microbiological profile included Gardnerella vaginalis, Neisseria gonorrhoeae, Trichomonas vaginalis, Candida albicans, Candida glabrata and Candida parapsilosis, predominantly in females on ages between 18 to 22 years.
Graph - Number of readers per month
Downloads
How to Cite
License
 |
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
| Copyright notice |
 |
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. |
|
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated. |
|
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access). |
| About the Creative Commons license |
|
|
You are free to: |
|
Share — copy and redistribute the material in any medium or format. |
|
Adapt — remix, transform, and build upon the material. |
|
The licensor cannot revoke these freedoms as long as you follow the license terms. |
Under the following terms: |
 |
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. |
 |
NonCommercial — You may not use the material for commercial purposes. |
 |
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. |